The landscape of dementia diagnosis has evolved significantly with the appearance of complex biomarkers, like amyloid PET scans, tau imaging, and blood-primarily based tests which will detect Alzheimer's pathology several years prior to symptoms emerge. While these technological developments signify exceptional progress in being familiar with neurodegenerative conditions, they have https://michaelx975xis5.wikipublicity.com/user